Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data

Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven sepsis (IDS), showed proof-of-concept with ...
News Medical

New method predicts sepsis and organ failure in children

University of Queensland researchers have developed a method to predict if a child is likely to develop sepsis and go into organ failure. Associate Professor Lachlan Coin from UQ's Institute for ...
News Medical

First-in-class drug could prevent sepsis-related organ failure and death

A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient's blood vessels. Researchers from The University of Queensland and the Queensland Children's ...
PhillyVoice

Montgomery County man survives rare, flesh-eating bacterial infection that caused sepsis, kidney failure

The North Wales community is rallying around Peter Atkinson and his family as he recovers from necrotizing fasciitis, which ...
CNN

Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis

– Final Analysis Comparing 10 Allocetra TM-Treated Patients with 37 Matched Controls Showed Significant Positive Responses in State of Organ Failure, ICU Hospitalization and Mortality in a Highly ...
Pharmabiz

Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data

Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...